Genesis Growth Equity Fund

Genesis Growth Equity Fund I (GGEF I), a fund focusing on smaller and mid-size high growth potential companies primarily in the Czech and Slovak markets, reached its hard cap size of € 40 million following the final closing of the Fund in December 2020 with additional commitments from SPM Capital and Sirius Investments.

“We are pleased to announce completion of the fundraising of Genesis Growth Equity Fund I with a final close reaching € 40 million thanks to support of number of reputable institutional LPs. The Fund was despite current challenging market conditions oversubscribed with the investor commitments reaching the hard cap amount.” comments on the successful fundraising of GGEF I Jiří Beneš, Managing Partner at Genesis Capital Growth.

“Regardless of last year being quite a difficult period for M&A transactions, we managed to close the first investments of GGEF I into two well-performing companies – R2B2 and Home Care Promedica. We look forward to deploying the Fund in the coming years as we see a number of high-growth potential businesses. These often face the issue of succession to the founders but are capable of using development capital efficiently.” added Radim Jasek, Partner at Genesis Capital Growth.

Genesis Growth Equity Fund I will invest equity tickets of up to € 4 million into established companies with a significant growth potential mainly in the Czech Republic and Slovakia, which plan on expanding their operations, grow internationally or invest into innovations. The GGEF I team sees a large number of exciting opportunities in this market segment and will provide entrepreneurs and companies with additional capital and support to back their business expansion.

During 2020 the Fund already completed its first two investments when it acquired majority stakes in R2B2, a leading provider of programmatic advertising services in the Czech Republic, and Home Care Promedica, an established provider of professional home health care services mainly in the Prague area.